Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Filippo de Braud

Showing results (1-10 of 497) with videos related to

Pageof 50
Sort By:
Critical Reviews in Oncology/Hematology|May 26, 2004
Cancer of pancreasFilippo de Braud, Stefano Cascinu, Gemma Gatta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Aprepitant versus dexamethasone for delayed emesis: what is the role of the 5-hydroxytryptamine type 3 receptor antagonist palonosetron?Luigi Celio, Filippo de Braud, Matti Aapro
Future Oncology (London, England)|May 12, 2017
The underestimated role of somatostatin analogs in the NETTER-1 trialSara Pusceddu, Roberto Buzzoni, Filippo de Braud
European Urology|April 11, 2012
Re: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol 2012;61:826-33Giuseppe Procopio, Elena Verzoni, Filippo De Braud
Patient Preference and Adherence|May 21, 2013
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomitingLuigi Celio, Francesca Ricchini, Filippo De Braud
The Lancet. Oncology|June 11, 2016
Improved quality of life is the way to longer lifeGiuseppe Procopio, Raffaele Ratta, Filippo de Braud
Oncology|October 19, 2012
Targeted therapies and survival: what we can learn from studies in advanced renal cell carcinomaGiuseppe Procopio, Elena Verzoni, Filippo de Braud
The New England Journal of Medicine|June 22, 2004
Drug-induced prolongation of the QT intervalGiuseppe Curigliano, Carlo Cipolla, Filippo de Braud
Frontiers in Oncology|October 17, 2019
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine TumorsClaudio Vernieri, Sara Pusceddu, Filippo de Braud
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Butterfly and renal cell cancer: out of chaos comes orderGiuseppe Procopio, Elena Verzoni, Filippo De Braud
Pageof 50

Showing results (1-10 of 497) with videos related to

Sort By:
Pageof 50
Critical Reviews in Oncology/Hematology|May 26, 2004
Cancer of pancreasFilippo de Braud, Stefano Cascinu, Gemma Gatta
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 11, 2014
Aprepitant versus dexamethasone for delayed emesis: what is the role of the 5-hydroxytryptamine type 3 receptor antagonist palonosetron?Luigi Celio, Filippo de Braud, Matti Aapro
Future Oncology (London, England)|May 12, 2017
The underestimated role of somatostatin analogs in the NETTER-1 trialSara Pusceddu, Roberto Buzzoni, Filippo de Braud
European Urology|April 11, 2012
Re: Camillo Porta, Emiliano Calvo, Miguel A. Climent, et al. Efficacy and safety of everolimus in elderly patients with metastatic renal cell carcinoma: an exploratory analysis of the outcomes of elderly patients in the RECORD-1 Trial. Eur Urol 2012;61:826-33Giuseppe Procopio, Elena Verzoni, Filippo De Braud
Patient Preference and Adherence|May 21, 2013
Safety, efficacy, and patient acceptability of single-dose fosaprepitant regimen for the prevention of chemotherapy-induced nausea and vomitingLuigi Celio, Francesca Ricchini, Filippo De Braud
The Lancet. Oncology|June 11, 2016
Improved quality of life is the way to longer lifeGiuseppe Procopio, Raffaele Ratta, Filippo de Braud
Oncology|October 19, 2012
Targeted therapies and survival: what we can learn from studies in advanced renal cell carcinomaGiuseppe Procopio, Elena Verzoni, Filippo de Braud
The New England Journal of Medicine|June 22, 2004
Drug-induced prolongation of the QT intervalGiuseppe Curigliano, Carlo Cipolla, Filippo de Braud
Frontiers in Oncology|October 17, 2019
Impact of Metformin on Systemic Metabolism and Survival of Patients With Advanced Pancreatic Neuroendocrine TumorsClaudio Vernieri, Sara Pusceddu, Filippo de Braud
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2014
Butterfly and renal cell cancer: out of chaos comes orderGiuseppe Procopio, Elena Verzoni, Filippo De Braud
Pageof 50